HOB Biotech Group Corp.,Ltd (688656.SS)
CNY 102.72
(-1.37%)
CNY 102.72
(-1.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 102.69 Million | 58.3 Million | 104.79 Million | 58.22 Million | 68.57 Million | 46.51 Million |
| Net Income | 47.33 Million | 41.65 Million | 86.19 Million | 56.61 Million | 63.83 Million | 40.15 Million |
| Depreciation & Amortization | 39.52 Million | 32.52 Million | 24.53 Million | 15.39 Million | 13.31 Million | 9.63 Million |
| Deferred income taxes | -735.14 Thousand | -1.25 Million | -661.59 Thousand | 1.63 Million | 414.31 Thousand | -1.85 Million |
| Stock-based compensation | 4.1 Million | 1.25 Million | - | - | - | 3.21 Million |
| Change in working capital | 3.77 Million | -18.76 Million | 2.45 Million | -2.81 Million | -10.68 Million | -17.11 Million |
| Other non-cash items | 10.46 Million | 2.89 Million | -8.39 Million | -10.97 Million | 2.1 Million | 13.83 Million |
| Investing Cash Flow | -39.54 Million | -343.86 Million | -154.39 Million | -35.03 Million | -33.75 Million | -25.38 Million |
| Investments in PPE | -178.03 Million | -220.2 Million | -167.88 Million | -57.01 Million | -34.79 Million | -26.65 Million |
| Acquisitions | 1.04 Million | 495.3 Thousand | 1.37 Million | 1.39 Million | 1.04 Million | 1.26 Million |
| Investment purchases | -381.5 Million | -895.5 Million | -1.37 Million | -1.39 Million | - | - |
| Sales/Maturities of investments | 518.94 Million | 771.34 Million | 12.11 Million | 20.58 Million | - | - |
| Other Investing Activities | 138.48 Million | 1.33 | 1.37 Million | 1.39 Million | 0.71 | 1.26 Million |
| Financing Cash Flow | -53.12 Million | -10.85 Million | 441.04 Million | -55.25 Million | -10.54 Million | 31.35 Million |
| Debt repayment | -25 Million | -20 Million | -43.95 Million | -66.06 Million | -24 Million | -43.95 Million |
| Dividends payments | -18.91 Million | -33.42 Million | -18.91 Million | -49.19 Million | -47.29 Million | -1.65 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -7.32 Million | 43.82 Million | 504.8 Million | 60 Million | 55 Million | 76.97 Million |
| Accounts receivables | -7.83 Million | -412.46 Thousand | -1.31 Million | -13.01 Million | -3.82 Million | -8.01 Million |
| Accounts payables | 35.76 Million | 1.43 Million | 10.69 Million | 10.87 Million | 3.19 Million | 3.18 Million |
| Inventory | -23.41 Million | -19.6 Million | -6.25 Million | -2.31 Million | -10.46 Million | -10.42 Million |
| Other working capital | 3.34 Million | -184.47 Thousand | -661.59 Thousand | 1.63 Million | 414.31 Thousand | -6.68 Million |
| Cash at beginning of period | 153.3 Million | 449.85 Million | 58.81 Million | 90.76 Million | 66.52 Million | 14.02 Million |
| Cash at end of period | 163.46 Million | 153.3 Million | 449.85 Million | 58.81 Million | 90.76 Million | 66.52 Million |
| Capital Expenditure | -178.03 Million | -220.2 Million | -167.88 Million | -57.01 Million | -34.79 Million | -26.65 Million |
| Effect of forex changes on cash | 135.81 Thousand | -141.7 Thousand | -406.35 Thousand | 115.18 Thousand | -37.11 Thousand | 20.98 Thousand |
| Net cash flow / Change in cash | 10.16 Million | -296.55 Million | 391.04 Million | -31.94 Million | 24.24 Million | 52.5 Million |
| Free Cash Flow | -75.33 Million | -161.9 Million | -63.09 Million | 1.21 Million | 33.77 Million | 19.85 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 6.58 Million | 16.17 Million | 3.8 Million | 47.33 Million | 8.69 Million | 17.06 Million |
| Depreciation & Amortization | - | 12.89 Million | 12.89 Million | 39.52 Million | 39.52 Million | -18.98 Million |
| Deferred income taxes | - | - | - | -735.14 Thousand | - | 32.59 Million |
| Stock-based compensation | - | - | - | 4.1 Million | 4.1 Million | -1.24 Million |
| Change in working capital | - | - | - | 3.77 Million | -27.9 Million | -12.36 Million |
| Other non-cash items | 27.2 Million | 31.15 Million | 4.32 Million | 10.46 Million | 10.78 Million | 13.78 Million |
| Investing Cash Flow | -23.03 Million | -25.53 Million | -80.34 Million | -39.54 Million | -27.12 Million | 19.14 Million |
| Investments in PPE | -23.12 Million | -25.7 Million | -80.57 Million | -178.03 Million | -53.16 Million | -43.31 Million |
| Acquisitions | 22 Thousand | 101 Thousand | - | 1.04 Million | 1.01 Million | -62.46 Million |
| Investment purchases | -47.5 Million | -45 Million | -30 Million | -381.5 Million | -38 Million | -71.5 Million |
| Sales/Maturities of investments | 47.56 Million | 45.06 Million | 30.22 Million | 518.94 Million | 63.01 Million | 133.96 Million |
| Other Investing Activities | - | 101 Thousand | 226.33 Thousand | 138.48 Million | 26.03 Million | 62.46 Million |
| Financing Cash Flow | 3.1 Million | -35.99 Million | 27.27 Million | -53.12 Million | -28.05 Million | -1.98 Million |
| Debt repayment | -5 Million | -10 Million | -30 Million | -25 Million | -24.87 Million | - |
| Dividends payments | - | -25.66 Million | -382.11 Thousand | -18.91 Million | -18.91 Million | -265.77 Thousand |
| Common Stock Repurchased | 20.01 Million | -20.01 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -21.9 Million | -23.32 Million | -2.34 Million | -7.32 Million | -2.2 Million | -1.71 Million |
| Accounts receivables | - | - | - | -7.83 Million | -7.83 Million | 6.78 Million |
| Accounts payables | - | - | - | 35.76 Million | - | 1.24 Million |
| Inventory | - | - | - | -23.41 Million | -23.41 Million | -19.14 Million |
| Other working capital | - | - | - | 3.34 Million | 3.34 Million | -1.24 Million |
| Cash at beginning of period | 91.28 Million | 118.37 Million | 163.46 Million | 153.3 Million | 187.51 Million | 139.76 Million |
| Cash at end of period | 105.13 Million | 91.28 Million | 118.37 Million | 163.46 Million | 163.46 Million | 187.51 Million |
| Capital Expenditure | -23.12 Million | -25.7 Million | -80.57 Million | -178.03 Million | -53.16 Million | -43.31 Million |
| Effect of forex changes on cash | - | 7426.78 | -153.53 Thousand | 135.81 Thousand | 34.94 Thousand | -267.61 Thousand |
| Net cash flow / Change in cash | 13.84 Million | -27.08 Million | -45.09 Million | 10.16 Million | -24.04 Million | 47.74 Million |
| Free Cash Flow | 10.66 Million | 8.73 Million | -72.44 Million | -75.33 Million | -22.06 Million | -12.47 Million |
RELY
SRHGF
EQT
ITC
TNABF
KOSCF